+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Factors associated with adherence amongst 5,295 people on antiretroviral therapy as part of an international trial



Factors associated with adherence amongst 5,295 people on antiretroviral therapy as part of an international trial







We assessed factors associated with antiretroviral therapy (ART) adherence including specific ART medications. The Strategies for Management of Antiretroviral Therapy study was an international ART treatment strategy trial that compared CD4+ T-cell-driven intermittent therapy to continuous ART. Adherence was measured using 7-day self-report. We defined high adherence as self-report of taking ‘all’ pills for each prescribed ART medication, all others had suboptimal adherence. Factors associated with adherence were assessed using logistic regression with generalized estimating equations. Participants reported suboptimal adherence in 6,016 (17%) of 35,695 study visits. Factors independently associated with suboptimal adherence were black race, protease inhibitor containing regimens, higher maximum number of doses per day and smoking. Factors independently associated with higher adherence were older age, higher education, region of residence, episodic treatment, higher latest (at time of adherence) CD4+ T-cell count and being prescribed concomitant drugs (medications for comorbidities). Of specific drugs investigated, atazanavir, atazanavir/r, fosamprenavir, indinavir, indinavir/r and lopinavir/r were associated with suboptimal adherence and tenofovir disoproxil fumarate/emtricitabine with higher adherence.In this, the largest analysis of ART adherence to date, some protease inhibitor containing regimens and regimens with more than one dose per day were associated with suboptimal adherence.

Accession: 036720786

Download citation: RISBibTeXText


Related references

Factors associated with adherence amongst 5295 people receiving antiretroviral therapy as part of an international trial. Journal of Infectious Diseases 208(1): 40-49, 2013

Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trial in Uganda and Zimbabwe. Journal of Acquired Immune Deficiency Syndromes 48(4): 468-475, 2008

Factors affecting adherence to antiretroviral therapy in people living with HIV/AIDS. Journal of the Association of Nurses in Aids Care 14(4): 37-45, 2003

Psychosocial factors in adherence to antiretroviral therapy among HIV-positive people who use drugs. Health Psychology 35(3): 290-297, 2016

Adherence to antiretroviral therapy and its associated factors among people living with HIV/AIDS in Addis Ababa, Ethiopia. Ethiopian Medical Journal 50(4): 355-361, 2012

Factors Influencing Adherence to Antiretroviral Therapy among People Living with HIV in Coastal South India. Journal of the International Association of Providers of Aids Care 15(6): 529-533, 2016

Factors associated with adherence to Antiretroviral Therapy (ART) among adult people living with HIV and attending their clinical care, Eastern Ethiopia. Bmc International Health and Human Rights 15: 33, 2015

Design, synthesis, and evaluation of the antiproliferative activity of hydantoin-derived antiandrogen-genistein conjugates. Bioorganic and Medicinal Chemistry 26(8): 1481-1487, 2018

Some factors associated with non-adherence to antiretroviral therapy (ART) in people living with HIV/AIDS (PLHA) in Tanzania: a case study of Dar es Salaam region. East African Journal of Public Health 8(4): 237-246, 2011

A Randomized Controlled Trial of Real-Time Electronic Adherence Monitoring With Text Message Dosing Reminders in People Starting First-Line Antiretroviral Therapy. Journal of Acquired Immune Deficiency Syndromes 70(5): 495-502, 2015

Protocol for a Randomized Controlled Trial Evaluating Mobile Text Messaging to Promote Retention and Adherence to Antiretroviral Therapy for People Living With HIV in Burkina Faso. Jmir Research Protocols 5(3): E170, 2016

Trends and determining factors associated with adherence to antiretroviral therapy (ART) in Cameroon: a systematic review and analysis of the CAMPS trial. Aids Research and Therapy 9(1): 37, 2012

Adherence as a predictor of sexual behaviors in people living with HIV/AIDS during the first year of antiretroviral therapy in rural Cameroon: data from Stratall ANRS 12110/ESTHER trial. Plos one 7(6): E36118, 2012

Adherence to antiretroviral therapy: factors independently associated with reported difficulty taking antiretroviral therapy in a national sample of HIV-positive Australians. HIV Medicine 12(9): 562-569, 2011

Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial. Lancet 385(9983): 2173-2182, 2015